Sandhill Capital Partners LLC decreased its stake in shares of Danaher Co. (NYSE:DHR – Free Report) by 4.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 98,520 shares of the conglomerate’s stock after selling 4,271 shares during the period. Danaher accounts for approximately 1.8% of Sandhill Capital Partners LLC’s holdings, making the stock its 22nd biggest holding. Sandhill Capital Partners LLC’s holdings in Danaher were worth $22,615,000 as of its most recent SEC filing.
A number of other institutional investors also recently modified their holdings of DHR. Gilbert & Cook Inc. increased its holdings in shares of Danaher by 2.5% in the fourth quarter. Gilbert & Cook Inc. now owns 1,749 shares of the conglomerate’s stock valued at $401,000 after purchasing an additional 42 shares in the last quarter. Grimes & Company Inc. increased its position in Danaher by 0.6% in the fourth quarter. Grimes & Company Inc. now owns 7,390 shares of the conglomerate’s stock worth $1,696,000 after purchasing an additional 43 shares during the period. Dakota Community Bank & Trust NA lifted its position in Danaher by 16.4% during the 4th quarter. Dakota Community Bank & Trust NA now owns 320 shares of the conglomerate’s stock valued at $73,000 after purchasing an additional 45 shares during the period. Howard Capital Management Group LLC grew its stake in shares of Danaher by 4.1% during the third quarter. Howard Capital Management Group LLC now owns 1,229 shares of the conglomerate’s stock worth $342,000 after purchasing an additional 48 shares during the period. Finally, Spinnaker Trust lifted its stake in Danaher by 1.2% in the fourth quarter. Spinnaker Trust now owns 4,304 shares of the conglomerate’s stock valued at $988,000 after buying an additional 50 shares during the period. 79.05% of the stock is owned by institutional investors.
Insider Activity at Danaher
In other news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction that occurred on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total value of $1,277,541.00. Following the completion of the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 11.10% of the stock is owned by insiders.
Wall Street Analyst Weigh In
Read Our Latest Stock Analysis on Danaher
Danaher Stock Performance
NYSE:DHR opened at $180.71 on Tuesday. The company has a current ratio of 1.40, a quick ratio of 1.05 and a debt-to-equity ratio of 0.31. The stock has a 50 day simple moving average of $208.60 and a 200 day simple moving average of $233.05. Danaher Co. has a 1-year low of $171.92 and a 1-year high of $281.70. The stock has a market cap of $129.15 billion, a P/E ratio of 34.22, a PEG ratio of 2.66 and a beta of 0.86.
Danaher (NYSE:DHR – Get Free Report) last announced its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter last year, the firm posted $2.09 EPS. Research analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.
Danaher Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Investors of record on Friday, March 28th will be given a $0.32 dividend. The ex-dividend date is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.71%. This is a boost from Danaher’s previous quarterly dividend of $0.27. Danaher’s dividend payout ratio (DPR) is presently 24.24%.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Alibaba Caught in Tariff Crossfire: Is It Time to Buy?
- 3 Stocks to Consider Buying in October
- Can Solid Biosciences Challenge Sarepta in the DMD Market?
- How to Calculate Return on Investment (ROI)
- Will CrowdStrike’s Goodwill Strategy Pay Off in Revenue Gains?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.